Hematopoietic SCT in Europe: Data and trends in 2012 with special consideration of pediatric transplantation

Bone Marrow Transplantation

Volumn 49, Issue 6, 2014, Pages 744-750

  Passweg, J R ^a   Baldomero, H ^a   Peters, C ^b   Gaspar, H B ^c   Cesaro, S ^d   Dreger, P ^e   Duarte, R F ^f   Falkenburg, J H F ^g   Farge Bancel, D ^h   Gennery, A ⁱ   Halter, J ^j   Kroger N ^k   Lanza, F ^l   Marsh, J ^m   Mohty, M ⁿ   Sureda, A ^o   Velardi, A ^p   Madrigal, A ^q  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Paediatric Haematology Oncology   (Italy)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f HOSPITAL DURAN I REYNALS   (Spain)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ Infectious Diseases Allergy   (United Kingdom)

^j JACIE Accreditation Committee   (Switzerland)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^l S ANNA HOSPITAL   (Italy)

^m KING'S COLLEGE LONDON   (United Kingdom)

ⁿ CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^o ADDENBROOKE S HOSPITAL   (United Kingdom)

^p SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^q ROYAL FREE HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; DONOR; DONOR LYMPHOCYTE INFUSION; EUROPE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MYELOPROLIFERATIVE NEOPLASM; NONHODGKIN LYMPHOMA; PEDIATRICS; PLASMACYTOMA; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SOLID TUMOR; TREND STUDY; UMBILICAL CORD BLOOD;

EID: 84902084387     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.55     Document Type: Article

References (18)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-1826.
2. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med 2007; 357: 1472-1475.
3. Ljungman P, Bregni M, Brune M, Cornelissen J, deWitte T, Dini G et al. European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 2010; 45: 219-234.
4. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010; 303: 1617-1624.
5. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Frauendorfer K et al. The EBMT activity survey 2008 impact of team size, team density and new trends. Bone Marrow Transplant 2011; 46: 174-191.
6. Gratwohl A. Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 1991; 8: 197-201.
7. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A. Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374-2386.
8. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Niederwieser D et al. Joint Accreditation Committee of the International Society for Cellular Therapy; European Group for Blood and Marrow Transplantation; European Leukemia Net. Predictability of hematopoietic stem cell transplantation rates. Haematologica 2007; 92: 1679-1686.
9. Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009; 43: 275-291.
10. Gratwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J, Niederwieser D et al. Changes in use of hematopoietic stem cell transplantation; a model for diffusion of medical technology. Haematologica 2010; 95: 637-643.
11. Martin I, Baldomero H, Bocelli-Tyndall C, Emmert MY, Hoerstrup SP, Ireland H et al. The survey on cellular and engineered tissue therapies in Europe in 2011. Tissue Eng Part A 2013; 20: 842-853.
12. Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012; 47: 906-923.
13. Passweg JR, Baldomero H, Bregni M, Cesaro S, Dreger P, Duarte RF et al. Hema-topoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant 2013; 48: 1161-1167.
14. Foeken LM, Green A, Hurley CK, Marry E, Wiegand T, Oudshoorn M. Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports. Bone Marrow Transplant 2010; 45: 811-818.
15. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009; 15: 1628-1633.
16. Schultz RK, Baker KS, Boelens JJ, Bollard CM, Egeler RM, Cowan M et al. Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group. Biol Blood Marrow Transplant 2013; 19: 1279-1287.
17. Gratwohl A, Brand R, Niederwieser D, Baldomero H, Chabannon C, Cornelissen J et al. Introduction of a Quality Management System and Outcome After Hema-topoietic Stem-Cell Transplantation. J Clin Oncol 2011; 29: 1980-1986.
18. Abou-Nassar E, Kim T, Blossom J, Ho V, Soiffer R, Cutler C et al. The Impact of Geographic Proximity to Transplant Center on Outcomes after Allogeneic Hematopoietic Stem Cell. Biology of Blood and Marrow Transplantation 2012; 18: 708-715.